HOPE Trials is a research arm of Quincy Bioscience and conducts human research studies to examine the effects of the dietary supplement ingredient apoaequorin in various health conditions.
The mission of HOPE Trials is to improve the quality of life for individuals suffering from a wide array of debilitating conditions linked by a common cause, a mismanagement of calcium at the cellular level.
HOPE Trials research consists of a variety of human trials measuring the effect of apoaequorin, a new dietary supplement ingredient, on cognitive functioning and quality of life.